slides · global inventory
Disclaimer
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 41,127
Current window 29,491-29,520
Pages 1,371
Rows per page 30
Component
29,491-29,520 of 41,127
02
23andMe | Investor Presentation Deck | 57 slides23andMe | Investor Presentation Deck | 57 slides · 23andMe
Pitch deck Investor relations 1 hit
20
The slide uses a 4-column layout to categorize service offerings, each paired with a mobile app UI screenshot.23andMe | Investor Presentation Deck | 57 slides · 23andMe
Pitch deck Investor relations Beat · Solution1 hit
35
The slide uses a gradient bar chart to represent the progression of drug development programs.23andMe | Investor Presentation Deck | 57 slides · 23andMe
Pitch deck Investor relations 1 hit
42
The slide uses a before-and-after diagram to illustrate the mechanism of action.23andMe | Investor Presentation Deck | 57 slides · 23andMe
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
45
The slide uses a process flow diagram to illustrate the study design (Part A to Part B).23andMe | Investor Presentation Deck | 57 slides · 23andMe
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
46
The slide outlines the mechanism of action, clinical rationale, and upcoming Phase 2a study design for the drug candidate.23andMe | Investor Presentation Deck | 57 slides · 23andMe
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
52
Fiscal year ends March 31.23andMe | Investor Presentation Deck | 57 slides · 23andMe
Pitch deck Investor relations 1 hit
05
The table uses a waterfall-style logic to explain the variance between two periods.3M | Results Presentation Deck | 20 slides · 3M
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
07
The slide serves as a visual index for the company's business units.3M | Results Presentation Deck | 20 slides · 3M
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
15
3M | Results Presentation Deck | 20 slides3M | Results Presentation Deck | 20 slides · 3M
Conference presentation Investor relations Beat · Action1 hit
18
The table includes a footnote clarifying the adjusted basis for specific segments.3M | Results Presentation Deck | 20 slides · 3M
Conference presentation Investor relations Beat · Action1 hit
04
Absci | Investor Presentation Deck | 27 slidesAbsci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · SetupLoop · Golden Circle1 hit
20
The chart uses a dot-plot visualization to represent cash flow magnitude over time, categorized by development stages.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · ActionLoop · Before After1 hit
21
The slide uses a table-like layout to present key company metrics as evidence of market readiness.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · ActionLoop · Before After1 hit
02
Aeglea BioTherapeutics | Investor Presentation Deck | 37 slidesAeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
03
The slide uses a list-based structure to categorize updates into clinical programs and corporate status.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
28
Includes histological images of liver tissue and a dot plot for bone mineral density (BMD).Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
35
The slide uses a flow diagram to illustrate the randomization process and study timeline.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
36
The table highlights specific clinical response metrics for six individual patients, demonstrating improvements and normalization of mobility scores.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
37
The slide uses a 2x2 matrix to describe the launch strategy.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
02
Alkermes | Results Presentation Deck | 21 slidesAlkermes | Results Presentation Deck | 21 slides · Alkermes
Conference presentation Investor relations Beat · Attention1 hit
05
Includes footnotes regarding non-GAAP reconciliation and royalty revenue impacts from Janssen license agreement.Alkermes | Results Presentation Deck | 21 slides · Alkermes
Conference presentation Investor relations Beat · Need1 hit
07
The slide includes a disclaimer regarding the date of the expectations and a note about non-GAAP reconciliation.Alkermes | Results Presentation Deck | 21 slides · Alkermes
Conference presentation Investor relations Beat · Need1 hit
13
The chart includes a vertical dashed line separating 2021 from 2022.Alkermes | Results Presentation Deck | 21 slides · Alkermes
Conference presentation Investor relations Beat · Need1 hit
20
The table reconciles GAAP net loss of $180M to non-GAAP net income of $20M using various non-cash and one-time adjustments.Alkermes | Results Presentation Deck | 21 slides · Alkermes
Conference presentation Investor relations Beat · Action1 hit
21
Alkermes | Results Presentation Deck | 21 slidesAlkermes | Results Presentation Deck | 21 slides · Alkermes
Conference presentation Investor relations Beat · Action1 hit
03
Vivid Seats | Results Presentation Deck | 23 slidesVivid Seats | Results Presentation Deck | 23 slides · Vivid Seats
Conference presentation Investor relations 1 hit
13
Includes a disclaimer regarding non-GAAP financial measures.Vivid Seats | Results Presentation Deck | 23 slides · Vivid Seats
Conference presentation Investor relations Beat · FinancialsLoop · Why Now1 hit
02
Yatsen | Results Presentation Deck | 19 slidesYatsen | Results Presentation Deck | 19 slides · Yatsen
Conference presentation Investor relations Beat · Attention1 hit
17
The slide provides a detailed breakdown of adjustments including share-based compensation, amortization, and investment revaluations.Yatsen | Results Presentation Deck | 19 slides · Yatsen
Conference presentation Investor relations Beat · Visualization1 hit